BL 01 Pill - blue round
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Pill with imprint BL 01 is Blue, Round and has been identified as Hyolev MB hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg. It is supplied by Burel Pharmaceuticals, Inc.
Hyolev MB is used in the treatment of Urinary Tract Infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Hyolev MB hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BL 01
Hyolev MB
- Generic Name
- hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
- Imprint
- BL 01
- Strength
- hyoscyamine sulfate 0.12 mg / methenamine 81 mg / methylene blue 10.8 mg / phenyl salicylate 32.4 mg / sodium phosphate monobasic 40.8 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 35573-0301 (Discontinued)
- Inactive Ingredients
-
lactose,
polyethylene glycol,
crospovidone,
magnesium stearate,
silicon dioxide,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Related images for "BL 01"
More about Hyolev MB (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Drug class: urinary antispasmodics
Patient resources
Other brands
Uribel, Uro-MP, Uretron DS, Phosphasal, ... +15 more
Professional resources
Other brands
Uribel, Uretron DS, Phosphasal, Urelle, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.